GLP-1 RA users incurred greater overall, third-party, and out-of-pocket expenditures compared to non-users, indicating significant economic impact.
Does GLP-1 RA use increase overall, third-party, and out-of-pocket expenditures in adults with diabetes in the United States?
GLP-1 RA use in US adults with diabetes is associated with increased healthcare expenditures, highlighting the need to balance clinical benefits with financial costs.
Absolute Event Rate: 0% vs 0%
One in 13 adults used GLP-1 RAs. GLP-1 RA users had greater overall, third-party, and out-of-pocket expenditures. These findings underscore the growing economic impact of GLP-1 RA use and highlight the importance of developing strategies that balance the proven clinical advantages of GLP-1 RAs against their financial burden.
Akpan et al. (Wed,) reported a other. GLP-1 RA users incurred greater overall, third-party, and out-of-pocket expenditures compared to non-users, indicating significant economic impact.